C
Catalyst Pharmaceuticals, Inc.
CN2 GF
CN2 GFCatalyst Pharmaceuticals, Inc.
GFFIGI: BBG000H5MZ52
GFVertex Pharmaceuticals Stock Shows Rising Relative Strength, Hits 80+
Amgen Stock Scores Relative Strength Rating Upgrade; Hits Key Benchmark
Axsome Therapeutics Stock Earns Relative Strength Rating Upgrade
ACELYRIN Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold
Exelixis Stock Sees Rising Relative Strength Rating
Catalyst Pharmaceuticals: Patrick McEnany to Retire as CEO by Year-End >CPRX
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Ultragenyx Pharm Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
Catalyst CEO Says 'We Hit The Ball Out Of The Park,' But Shares Of IBD 50 Stock Crash
Cassava Sciences Stock Clears Benchmark, Hitting 80-Plus RS Rating
Catalyst Pharmaceuticals 1Q EPS 26c >CPRX
Immunogen Stock Shows Market Leadership With Jump To 99 RS Rating
How To Invest: Accelerating Profit Growth Often Marks Winning Stocks Before Their Big Runs
Vertex Pharmaceuticals Stock Sees Composite Rating Edge Up To 96
No. 1 Biotech Catalyst Pharma Surges On 2023 Expectations
Companies Push Back Against Cost of Robinhood Stock Giveaway
Regulators Eye a Robinhood Marketing Ploy: Free Shares
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.